You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumors Cancer (1)

Non Small Cell Lung Cancer (NSCLC) (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

AbbVie (1)

Collaborator

Intervention

abbv-637 (1)

docetaxel (1)

osimertinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

abbv-637

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Tumors Cancer, Non Small Cell Lung Cancer (NSCLC) Trial in Worldwide (ABBV-637, Docetaxel, Osimertinib)

Recruiting

Advanced Solid Tumors Cancer
Non Small Cell Lung Cancer (NSCLC)

ABBV-637
+2 more

Boston, Massachusetts
+32 more

Dec 9, 2022